Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation

Lindsey Mayo, Steven J. Berberich

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In this study, we set out to assess whether the p53 protein affects mdm-2 gene expression as F9 embryonal carcinoma cells differentiate into parietal endoderm cells. It was previously reported that F9 cells possess abundant levels of wild-type p53 and upon induction to differentiate, p53 mRNA and protein levels decrease. We demonstrate that while p53 mRNA and protein levels decrease as F9 cells differentiate, mdm-2 mRNA and protein expression remains constitutive. Using RNA primer extension assays, rye determined that the mdm-2 mRNA expression is not directed by p53 in either F9 embryonal (undifferentiated) or parietal endoderm (differentiated) cells. However, p53 protein does stimulate mdm-2 mRNA expression in response to u.v. irradiation. The inability of p53 to transactivate mdm-2 in undamaged F9 cells was not the result of latent pools as p53 sequence specific DNA binding activity was observed using electrophoretic mobility shift assays. Our results suggest that, in F9 cells, the p53:Mdm-2 autoregulatory loop is confined to pathways governing DNA damage.

Original languageEnglish (US)
Pages (from-to)2315-2321
Number of pages7
JournalOncogene
Volume13
Issue number11
StatePublished - 1996
Externally publishedYes

Fingerprint

Cell Differentiation
Proto-Oncogene Proteins c-mdm2
Messenger RNA
Genes
Endoderm
Proteins
Embryonal Carcinoma Stem Cells
Electrophoretic Mobility Shift Assay
DNA Damage
Gene Expression

Keywords

  • F9 cellular differentiation
  • mdm-2
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation. / Mayo, Lindsey; Berberich, Steven J.

In: Oncogene, Vol. 13, No. 11, 1996, p. 2315-2321.

Research output: Contribution to journalArticle

@article{ddc72ee95c6847e8be1275415f354677,
title = "Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation",
abstract = "In this study, we set out to assess whether the p53 protein affects mdm-2 gene expression as F9 embryonal carcinoma cells differentiate into parietal endoderm cells. It was previously reported that F9 cells possess abundant levels of wild-type p53 and upon induction to differentiate, p53 mRNA and protein levels decrease. We demonstrate that while p53 mRNA and protein levels decrease as F9 cells differentiate, mdm-2 mRNA and protein expression remains constitutive. Using RNA primer extension assays, rye determined that the mdm-2 mRNA expression is not directed by p53 in either F9 embryonal (undifferentiated) or parietal endoderm (differentiated) cells. However, p53 protein does stimulate mdm-2 mRNA expression in response to u.v. irradiation. The inability of p53 to transactivate mdm-2 in undamaged F9 cells was not the result of latent pools as p53 sequence specific DNA binding activity was observed using electrophoretic mobility shift assays. Our results suggest that, in F9 cells, the p53:Mdm-2 autoregulatory loop is confined to pathways governing DNA damage.",
keywords = "F9 cellular differentiation, mdm-2, p53",
author = "Lindsey Mayo and Berberich, {Steven J.}",
year = "1996",
language = "English (US)",
volume = "13",
pages = "2315--2321",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation

AU - Mayo, Lindsey

AU - Berberich, Steven J.

PY - 1996

Y1 - 1996

N2 - In this study, we set out to assess whether the p53 protein affects mdm-2 gene expression as F9 embryonal carcinoma cells differentiate into parietal endoderm cells. It was previously reported that F9 cells possess abundant levels of wild-type p53 and upon induction to differentiate, p53 mRNA and protein levels decrease. We demonstrate that while p53 mRNA and protein levels decrease as F9 cells differentiate, mdm-2 mRNA and protein expression remains constitutive. Using RNA primer extension assays, rye determined that the mdm-2 mRNA expression is not directed by p53 in either F9 embryonal (undifferentiated) or parietal endoderm (differentiated) cells. However, p53 protein does stimulate mdm-2 mRNA expression in response to u.v. irradiation. The inability of p53 to transactivate mdm-2 in undamaged F9 cells was not the result of latent pools as p53 sequence specific DNA binding activity was observed using electrophoretic mobility shift assays. Our results suggest that, in F9 cells, the p53:Mdm-2 autoregulatory loop is confined to pathways governing DNA damage.

AB - In this study, we set out to assess whether the p53 protein affects mdm-2 gene expression as F9 embryonal carcinoma cells differentiate into parietal endoderm cells. It was previously reported that F9 cells possess abundant levels of wild-type p53 and upon induction to differentiate, p53 mRNA and protein levels decrease. We demonstrate that while p53 mRNA and protein levels decrease as F9 cells differentiate, mdm-2 mRNA and protein expression remains constitutive. Using RNA primer extension assays, rye determined that the mdm-2 mRNA expression is not directed by p53 in either F9 embryonal (undifferentiated) or parietal endoderm (differentiated) cells. However, p53 protein does stimulate mdm-2 mRNA expression in response to u.v. irradiation. The inability of p53 to transactivate mdm-2 in undamaged F9 cells was not the result of latent pools as p53 sequence specific DNA binding activity was observed using electrophoretic mobility shift assays. Our results suggest that, in F9 cells, the p53:Mdm-2 autoregulatory loop is confined to pathways governing DNA damage.

KW - F9 cellular differentiation

KW - mdm-2

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0030443684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030443684&partnerID=8YFLogxK

M3 - Article

C2 - 8957072

AN - SCOPUS:0030443684

VL - 13

SP - 2315

EP - 2321

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -